161 related articles for article (PubMed ID: 13680166)
21. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation.
Safdar A; Rodriguez G; Ohmagari N; Kontoyiannis DP; Rolston KV; Raad II; Champlin RE
Cancer; 2005 Feb; 103(4):731-9. PubMed ID: 15641032
[TBL] [Abstract][Full Text] [Related]
22. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ruhnke M; Böhme A; Buchheidt D; Donhuijsen K; Einsele H; Enzensberger R; Glasmacher A; Gümbel H; Heussel CP; Karthaus M; Lambrecht E; Südhoff T; Szelényi H;
Ann Hematol; 2003 Oct; 82 Suppl 2():S141-8. PubMed ID: 13680169
[TBL] [Abstract][Full Text] [Related]
24. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
25. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia.
Baskaran ND; Gan GG; Adeeba K; Sam IC
Int J Infect Dis; 2007 Nov; 11(6):513-7. PubMed ID: 17459753
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of war wound infection].
Kucisec-Tepes N; Bejuk D; Kosuta D
Acta Med Croatica; 2006 Sep; 60(4):353-63. PubMed ID: 17048790
[TBL] [Abstract][Full Text] [Related]
27. Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation.
Lee MY; Chiou TJ; Hsiao LT; Yang MH; Lin PC; Poh SB; Yen CC; Liu JH; Teng HW; Chao TC; Wang WS; Chen PM
Ann Hematol; 2008 Apr; 87(4):285-9. PubMed ID: 17943285
[TBL] [Abstract][Full Text] [Related]
28. Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America).
Kirby JT; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):75-82. PubMed ID: 16876375
[TBL] [Abstract][Full Text] [Related]
29. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
Durnaá B; Dzierzanowska D
Wiad Lek; 2006; 59(7-8):506-11. PubMed ID: 17209349
[TBL] [Abstract][Full Text] [Related]
30. Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation.
Lövenich H; Schütt-Gerowitt H; Keulertz C; Waldschmidt D; Bethe U; Söhngen D; Cornely OA
Bone Marrow Transplant; 2005 May; 35(10):997-1001. PubMed ID: 15806134
[TBL] [Abstract][Full Text] [Related]
31. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
Janković B; Pasić S; Marković M; Veljković D; Milicić M
Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
[TBL] [Abstract][Full Text] [Related]
32. Empiric therapy for febrile neutropenia: what are the choices?
Aoun M
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):507-15. PubMed ID: 17547514
[TBL] [Abstract][Full Text] [Related]
33. Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation.
Geisler WM; Malhotra U; Stamm WE
Bone Marrow Transplant; 2001 Dec; 28(12):1171-3. PubMed ID: 11803363
[TBL] [Abstract][Full Text] [Related]
34. Febrile neutropenia. Etiology of infection, empirical treatment and prophylaxis.
Eltahawy AT
Saudi Med J; 2003 Apr; 24(4):331-6. PubMed ID: 12754528
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
[TBL] [Abstract][Full Text] [Related]
36. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
38. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?
Lipsky BA
Clin Microbiol Infect; 2007 Apr; 13(4):351-3. PubMed ID: 17359317
[TBL] [Abstract][Full Text] [Related]
39. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
40. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment.
Hedrick J
Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
